ArticleCurrent issues in molecular biology2025

PRMT5 Inhibition as a Potential Strategy for KRAS Mutant CRC: Downstream Mediators of the PRMT5-KRAS Crosstalk.

Mark Spivak et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.